Recent advances in Oral Oncology

Oral Oncology

Volumn 43, Issue 2, 2007, Pages 107-115

  Scully, Crispian ^a   Bagan, Jose V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Carcinoma; Invasion; Oral; Pathogenesis; Prognosis; Treatment

Indexed keywords

ACYLTRANSFERASE; ALCOHOL; ALCOHOL DEHYDROGENASE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ARACHIDONATE 15 LIPOXYGENASE; CISPLATIN; CYTOCHROME P450; DOCETAXEL; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; FOLINIC ACID; FUMAGILLOL CHLOROACETYLCARBAMATE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 4; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE 3; OXALIPLATIN; TALAPORFIN; TRANSFORMING GROWTH FACTOR BETA;

CLINICAL FEATURE; CLINICAL RESEARCH; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; MUCOSA INFLAMMATION; NECROSIS; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; PROGNOSIS; QUALITY OF LIFE;

EID: 33846593409     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.12.007     Document Type: Review

References (80)

1. Tilakaratne W.M., Klinikowski M.F., Saku T., Peters T.J., and Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42 6 (2006) 561-568
2. Mukherjee A., Paul R.R., Chaudhuri K., Chatterjee J., Pal M., Banerjee P., et al. Performance analysis of different wavelet feature vectors in quantification of oral precancerous condition. Oral Oncol 42 9 (2006) 914-928
3. Mignogna M.D., Fedele S., and Lo Russo L. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 42 8 (2006) 819-824
4. Gandolfo S., Pentenero M., Broccoletti R., Pagano M., Carrozzo M., and Scully C. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 42 1 (2006) 89-95
5. Kujan O., Oliver R.J., Khattab A., Roberts S.A., Thakker N., and Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42 10 (2006) 987-993
6. Fan G.K., Chen J., Ping F., and Geng Y. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 42 2 (2006) 147-153
7. Acay R.R., Felizzola C.R., de Araujo N., and de Sousa S.O. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol 42 5 (2006) 475-480
8. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42 5 (2006) 461-474
9. Conway D.I., Stockton D.L., Warnakulasuriya K.A., Ogden G., and Macpherson L.M. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol 42 6 (2006) 586-592
10. Mognetti B., Di Carlo F., and Berta G.N. Animal models in oral cancer research. Oral Oncol 42 5 (2006) 448-460
11. Ogawa K., Tanuma J., Hirano M., Hirayama Y., Semba I., Shisa H., et al. Selective loss of resistant alleles at p15INK4B and p16INK4A genes in chemically-induced rat tongue cancers. Oral Oncol 42 7 (2006) 710-717
12. Huang X., Wei Y., Li L., Wen Y., Yang J., Liu B., et al. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 42 1 (2006) 26-31
13. Kim M.M., Glazer C.A., Mambo E., Chatterjee A., Zhao M., Sidransky D., et al. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. Oral Oncol 42 2 (2006) 201-207
14. Bosetti C., Gallus S., Garavello W., and La Vecchia C. Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol 42 10 (2006) 957-964
15. Bosetti C., Garavello W., Gallus S., and Vecchia C.L. Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies. Oral Oncol 42 9 (2006) 866-872
16. Kurkivuori J., Salaspuro V., Kaihovaara P., Kari K., Rautemaa R., Gronroos L., et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol (2006) Jul 19; [Epub ahead of print]
17. Kujan O., Desai M., Sargent A., Bailey A., Turner A., and Sloan P. Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa. Oral Oncol 42 8 (2006) 810-818
18. Parker T.M., Smith E.M., Ritchie J.M., Haugen T.H., Vonka V., Turek L.P., et al. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol 42 3 (2006) 288-296
19. Campisi G., Giovannelli L., Calvino F., Matranga D., Colella G., Di Liberto C., et al. HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. Oral Oncol 42 6 (2006) 638-645
20. Marques C.F., Koifman S., Koifman R.J., Boffetta P., Brennan P., and Hatagima A. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 42 6 (2006) 632-637
21. Sathyan K.M., Nalinakumari K.R., Abraham T., and Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42 6 (2006) 607-613
22. Wang L., Liu T., Nishioka M., Aguirre R.L., Win S.S., and Okada N. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 42 6 (2006) 625-631
23. Auerkari E.I. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42 1 (2006) 5-13
24. Miyazaki H., Patel V., Wang H., Ensley J.F., Gutkind J.S., and Yeudall W.A. Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. Oral Oncol 42 3 (2006) 240-256
25. O-Charoenrat P., and Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 42 3 (2006) 257-267
26. Cao Z.G., and Li C.Z. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42 1 (2006) 32-38
27. Lin M.H., Liu S.Y., Su H.J., and Liu Y.C. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma. Oral Oncol 42 9 (2006) 907-913
28. Vairaktaris E., Yapijakis C., Serefoglou Z., Vylliotis A., Ries J., Nkenke E., et al. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42 9 (2006) 888-892
29. Shieh D.B., Chen I.W., Wei T.Y., Shao C.Y., Chang H.J., Chung C.H., et al. Tissue expression of gelsolin in oral carcinogenesis progression and its clinicopathological implications. Oral Oncol 42 6 (2006) 599-606
30. Bas M., Bier H., Schirlau K., Friebe-Hoffmann U., Scheckenbach K., Balz V., et al. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck. Oral Oncol 42 7 (2006) 691-697
31. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 3 (2006) 229-239
32. Derka S., Vairaktaris E., Papakosta V., Vassiliou S., Acil Y., Vylliotis A., et al. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 42 5 (2006) 540-550
33. Diniz-Freitas M., Garcia-Caballero T., Antunez-Lopez J., Gandara-Rey J.M., and Garcia-Garcia A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42 2 (2006) 190-200
34. Kuratomi Y., Kumamoto M., Kidera K., Toh S., Masuda M., Nakashima T., et al. Diffuse expression of laminin gamma2 chain in disseminating and infiltrating cancer cells indicates a highly malignant state in advanced tongue cancer. Oral Oncol 42 1 (2006) 73-76
35. Mathe M., Suba Z., Nemeth Z., Tatrai P., Fule T., Borgulya G., et al. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 42 5 (2006) 493-500
36. Wang X., Fan M., Chen X., Wang S., Alsharif M.J., Wang L., et al. Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma. Oral Oncol 42 7 (2006) 740-744
37. Swinson B., Jerjes W., El-Maaytah M., Norris P., and Hopper C. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol 42 3 (2006) 221-228
38. Lindeboom J.A., Mathura K.R., and Ince C. Orthogonal polarization spectral (OPS) imaging and topographical characteristics of oral squamous cell carcinoma. Oral Oncol 42 6 (2006) 581-585
39. Downer M.C., Moles D.R., Palmer S., and Speight P.M. A systematic review of measures of effectiveness in screening for oral cancer and precancer. Oral Oncol 42 6 (2006) 551-560
40. Lopez-Jornet P., and Camacho-Alonso F. New barriers in oral cancer. Patient accessibility to dental examination - a pilot study. Oral Oncol 42 10 (2006) 1022-1025
41. Reid B.C., and Rozier R.G. Continuity of care and early diagnosis of head and neck cancer. Oral Oncol 42 5 (2006) 510-516
42. Wong Y.K., Tsai W.C., Lin J.C., Poon C.K., Chao S.Y., Hsiao Y.L., et al. Socio-demographic factors in the prognosis of oral cancer patients. Oral Oncol 42 9 (2006) 893-906
43. Liao C.T., Wang H.M., Hsieh L.L., Chang J.T., Ng S.H., Hsueh C., et al. Higher distant failure in young age tongue cancer patients. Oral Oncol 42 7 (2006) 718-725
44. van de Pol S.M., Doornaert P.A., de Bree R., Leemans C.R., Slotman B.J., and Langendijk J.A. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol 42 2 (2006) 131-138
45. Rumboldt Z., Day T.A., and Michel M. Imaging of oral cavity cancer. Oral Oncol 42 9 (2006) 854-865
46. Brouwer J., Senft A., de Bree R., Comans E.F., Golding R.P., Castelijns J.A., et al. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?. Oral Oncol 42 3 (2006) 275-280
47. Kunkel M., Helisch A., Reichert T.E., Jeong J.H., Buchholz H.G., Benz P., et al. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oralsquamous cell carcinoma after surgical salvage therapy. Oral Oncol 42 3 (2006) 297-305
48. Cantu G., Bimbi G., Colombo S., Compan A., Gilardi R., Pompilio M., et al. Lip-splitting in transmandibular resections: is it really necessary?. Oral Oncol 42 6 (2006) 619-624
49. Liao C.T., Wang H.M., Ng S.H., Yen T.C., Lee L.Y., Hsueh C., et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 42 8 (2006) 800-809
50. Ferlito A., Rinaldo A., Silver C.E., Gourin C.G., Shah J.P., Clayman G.L., et al. Elective and therapeutic selective neck dissection. Oral Oncol 42 1 (2006) 14-25
51. Wei W.I., Ferlito A., Rinaldo A., Gourin C.G., Lowry J., Ho W.K., et al. Management of the N0 neck-reference or preference. Oral Oncol 42 2 (2006) 115-122
52. Lim Y.C., Choi E.C., Lee J.S., Koo B.S., Song M.H., and Shin H.A. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?. Oral Oncol 42 1 (2006) 102-107
53. Keski-Santti H., Atula T., Tornwall J., Koivunen P., and Makitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 42 1 (2006) 96-101
54. Pathak K.A., Das A.K., Agarwal R., Talole S., Deshpande M.S., Chaturvedi P., et al. Selective neck dissection (I-III) for node negative and node positive necks. Oral Oncol 42 8 (2006) 837-841
55. Lee S.Y., Lim Y.C., Song M.H., Lee J.S., Koo B.S., and Choi E.C. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma. Oral Oncol 42 10 (2006) 1017-1021
56. Coppen C., de Wilde P.C., Pop L.A., van den Hoogen F.J., and Merkx M.A. Treatment results of patients with a squamous cell carcinoma of the buccal mucosa. Oral Oncol 42 8 (2006) 795-799
57. Chang H.W., Kim S.Y., Yi S.L., Son S.H., Song do Y., Moon S.Y., et al. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral Oncol 42 10 (2006) 979-986
58. Shintani S., Li C., Mihara M., Klosek S.K., Terakado N., Hino S., and Hamakawa H. Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma. Oral Oncol 42 1 (2006) 66-72
59. Rapidis A.D., Trichas M., Stavrinidis E., Roupakia A., Ioannidou G., Kritselis G., et al. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a 4-year follow-up. Oral Oncol 42 7 (2006) 675-684
60. Raguse J.D., Gath H.J., Oettle H., and Bier J. Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: a phase II feasibility study. Oral Oncol 42 6 (2006) 614-618
61. Chufal K.S., Rastogi M., Srivastava M., Pant M.C., and Bhatt M.L. Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: a pragmatic approach for locally advanced head and neck squamous cell carcinoma. Oral Oncol 42 5 (2006) 517-525
62. Yoshitomi I., Kawasaki G., Yanamoto S., and Mizuno A. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil. Oral Oncol 42 9 (2006) 880-887
63. Yamamoto T., Oku N., Tatemoto Y., Ueta E., Kamatani T., Sasabe E., and Osaki T. Concomitant chemo-radio-immunotherapy has a lethal therapeutic effect on tongue carcinomas independent of the clinical stage and histological characteristics of the tumor. Oral Oncol 42 9 (2006) 873-879
64. Dasgupta S., Tripathi P.K., Qin H., Bhattacharya-Chatterjee M., Valentino J., and Chatterjee S.K. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol 42 3 (2006) 306-316
65. Tsushima F., Tanaka K., Otsuki N., Youngnak P., Iwai H., Omura K., et al. Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. Oral Oncol 42 3 (2006) 268-274
66. Bose A., Ghosh D., Pal S., Mukherjee K.K., Biswas J., and Baral R. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling. Oral Oncol 42 2 (2006) 161-171
67. Kim J.H., Chang J.H., Yoon J.H., Lee J.G., Bae J.H., and Kim K.S. 15-Lipoxygenase-1 induced by interleukin-4 mediates apoptosis in oral cavity cancer cells. Oral Oncol 42 8 (2006) 825-830
68. Dube A., Sharma S., and Gupta P.K. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Oral Oncol 42 1 (2006) 77-82
69. Kobayashi W., Liu Q., Nakagawa H., Sakaki H., Teh B., Matsumiya T., et al. Photodynamic therapy with mono-l-aspartyl chlorin e6 can cause necrosis of squamous cellcarcinoma of tongue: experimental study on an animal model of nude mouse. Oral Oncol 42 1 (2006) 46-50
70. Togashi H., Uehara M., Ikeda H., and Inokuchi T. Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft. Oral Oncol 42 5 (2006) 526-532
71. Llewellyn C.D., McGurk M., and Weinman J. How satisfied are head and neck cancer (HNC) patients with the information they receive pre-treatment? Results from the satisfaction with cancer information profile (SCIP). Oral Oncol 42 7 (2006) 726-734
72. Rogers S.N., O'donnell J.P., Williams-Hewitt S., Christensen J.C., and Lowe D. Health-related quality of life measured by the UW-QoL - reference values from a general dental practice. Oral Oncol 42 3 (2006) 281-287
73. Markkanen-Leppanen M., Isotalo E., Makitie A.A., Asko-Seljavaara S., Pessi T., Suominen E., et al. Changes in articulatory proficiency following microvascular reconstruction in oral or oropharyngeal cancer. Oral Oncol 42 6 (2006) 646-652
74. Toporcov T.N., and Antunes J.L. Restrictions of food intake in patients with oral cancer. Oral Oncol 42 9 (2006) 929-933
75. Markkanen-Leppanen M., Isotalo E., Makitie A.A., Rorarius E., Asko-Seljavaara S., Pessi T., et al. Swallowing after free-flap reconstruction in patients with oral and pharyngeal cancer. Oral Oncol 42 5 (2006) 501-509
76. Nesse W., Hoekema A., Stegenga B., van der Hoeven J.H., de Bont L.G., and Roodenburg J.L. Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol 42 1 (2006) 108-114
77. Chambers M.S., Mellberg J.R., Keene H.J., Bouwsma O.J., Garden A.S., Sipos T., et al. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides. Oral Oncol 42 9 (2006) 934-945
78. Chambers M.S., Mellberg J.R., Keene H.J., Bouwsma O.J., Garden A.S., Sipos T., et al. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study. Oral Oncol 42 9 (2006) 946-953
79. Davies A.N., Brailsford S.R., and Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 42 7 (2006) 698-702
80. Bagg J., Jackson M.S., Petrina Sweeney M., Ramage G., and Davies A.N. Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer. Oral Oncol 42 5 (2006) 487-492